 Image copyright PA Image caption Charlie Gard has been in intensive care since October 
 
 Great Ormond Street Hospital has applied for a fresh hearing in the case of Charlie Gard following claims of "new evidence relating to potential treatment for his condition". Image caption Under a High Court ruling, GOSH is forbidden from allowing Charlie to be transferred for nucleoside therapy anywhere 
 
 A hospital spokesman said: "Two international hospitals and their researchers have communicated to us as late as the last 24 hours that they have fresh evidence about their proposed experimental treatment. “And we believe, in common with Charlie’s parents, it is right to explore this evidence.” Great Ormond Street Hospital is bound by the ruling of the High Court which expressly forbids us from transferring Charlie for nucleoside therapy anywhere. But they lost a legal battle with the hospital last month when judges at the European Court of Human Rights ruled further treatment would "continue to cause Charlie significant harm". The ruling of Mr Justice Francis states: “It is lawful, and in Charlie’s best interests not to undergo nucleoside therapy, provided always that the measures and treatments adopted are the most compatible with maintaining Charlie’s dignity.” 
 
 Great Ormond Street Hospital is therefore giving the High Court the opportunity to objectively assess the claims of fresh evidence. "It will be for the High Court to make its judgment on the facts. 'Tested on mice' 
 
 Seven clinicians and researchers, including the US doctor, signed a letter explaining that the treatment would be experimental for Charlie's particular condition. On Friday afternoon, however, the hospital changed course. We believe it is right to seek the High Court’s view in light of the claimed new evidence. "Our priority has always been, and will always be, the best interests of Charlie Gard."
– In the latest turn in the Charlie Gard saga, a London hospital says it will not turn off life support for the brain-damaged baby as it seeks a new court opinion, the New York Times reports. The about-face came Friday after the hospital received "claims of fresh evidence" for an experimental treatment. Two international hospitals approached 11-month-old Charlie's doctors to propose a new therapy "and we believe … it is right to explore this evidence," Great Ormond Street Hospital says. Charlie's parents say an experimental treatment in the US could help the infant, who suffers from a rare genetic disorder with no cure. The London high court that approved unplugging Charlie and forbade his transfer will reconsider the case on Monday, per the BBC. The hospital's decision came even as doctors there still believe the boy has "catastrophic" brain damage and that treatment would be "futile." Great Ormond did not identify the hospitals, but one in New York City—New York Presbyterian Hospital and Columbia University Irving Medical Center—offered to treat the child after his parents' pleas went global. The Vatican and President Trump also pledged support. Charlie's parents pinned their hopes to an unidentified US neurologist who proposed trying nucleoside therapy, which helped a boy with a less severe form of the same disease. It has never been tried in someone with Charlie's form of TK2 syndrome, and even the doctor who pitched it concedes its efficacy in Charlie's case was only "theoretical" and the results unknown, per the Times. "There’s around a 10% chance of this working for Charlie," mom Connie Yates says, without citing evidence.